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LETTER TO THE EDITOR
Five Years Allograft Survival of Renal Transplants: 
A Single Center Study 
 
 
Dear Editor, 
Renal transplantation is the treatment of choice for vast 
majority of patients with end-stage renal disease.
1 
Marked improvements in early graft survival and graft 
function have resulted in kidney transplantation being 
a cost-effective alternative to dialysis.
2 Among the 
most age groups and etiologies of end-stage renal dis-
ease,  renal transplantation prolongs patient lifespan.
3,4 
Accordingly in this study, short and long-term follow 
ups of patients undergoing kidney transplant were 
evaluated in a thirteen-year cohort study. 
In this cohort study, 306 consecutive patients (age 
from 11 to 66 years) with end -stage renal disease 
(ESRD) between 1995 and 2008 attending to our in-
stitution were recruited. They were selected in a cen-
sus manner. Procedure of surgery was usually per-
formed consecutively by the same surgical team. Im-
munosuppressive regimens were based on a similar 
protocol. All patients were followed up routinely in 
our center. The Shahid-Beheshti Ethical Committee 
approved this study and the study was performed in 
accordance with the declaration of Helsinki. 
The variables included age, sex, race, BMI, social 
class, alive or dead status of kidney donor, 
hypertensive status, BUN and creatinine in one month, 
one year, and five years after kidney transplantation. 
The exact time of transplantation was considered to be 
the initial event, and irreversible loss of renal allograft 
(when the patients needed regular dialysis again) was 
defined as the end-point event. Data were collected 
through review of hospital and nephrology clinic 
records. The organ survival and return to regular 
dialysis were assessed and determined by 
nephrologists in follow up records in the clinic. 
After testing for normal distribution by Kolmogorov-
Smirnov test, continuous data were
 compared by t test 
and categorical data were compared by the Chi-Square 
and Fisher Exact tests. For analyzing survival rate, 
Kaplan-Meier method was applied .Survival data were 
analyzed by running SPSS software (Version 16, Chica-
go, IL, USA). Differences with
  a  p<0.05 in analysis 
were considered as statistically significant. 
The mean age of the patients was 35±24 years 
(range=11-66 years), 126 subjects (41.18%) were fe-
male and 180 patients (58.82%) were male. Two pa-
tients were on peritoneal dialysis, 28 cases had no histo-
ry of dialysis, and the other subjects were on hemodialy-
sis, before the kidney transplantation was performed. All 
patients were on immuno-suppressors after the trans-
plantation. 290 out of 306 cases of donors were living 
and 16 out of 306 were cadavers. The mean duration of 
follow up in this study was 50±30.6 months.  
The one-month graft and patients survival rate 
were 93.5±0.5% and 99.3±0.4% respectively. There 
were 20 cases of graft loss (6.53%) in the first month 
that six cases were for accelerated rejection and four-
teen were for venoarterial thrombosis. The one-year 
graft and patients survival rate were 86.89±0.6% and 
96.54±0.3% respectively. The five-year graft and pa-
tient's survival rate were 81±0.8%and 85±0.5% re-
spectively. The recorded BUN and creatinine levels 
were shown in Table 1 after one month, one year, and 
five year follow ups.  
Kidney transplantation is the treatment of choice in 
patients with end-stage renal disease because it results 
in better survival and quality of life. It has been report-
ed that racial and socioeconomic variations may influ-
ence the results of kidney transplantation. Hence per-
forming studies in different populations seems neces-
sary.
5,6 In Vergoulas study, it was seen that the patient 
survival at 1 year was 93.1%-100%. Graft survival at 1 
and 5 years was 100%. We had a relatively similar fre-
quency in our studies.
7 
Totally, according to the obtained results in this 
study and comparison with previous similar studies, it 
may be concluded that our patients had a similar 
Table 1: BUN and creatinine levels after 1 month, 1 year, and 5 years.
Time  BUN (mg/dl) Creatinine (mg/dl) 
Range Mean Range Mean 
After 1 month  6-46  28±10.5  0.5-2.6  1.1±0.5 
After 1 year  11-64  30±14.3  0.7-2.8  1.3±0.6 
After 5 years  15-78  38±26.5  0.8-3.2  1.56±1.8 Allograft survival in renal transplants 
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prognosis compared with previous reports. It is rec-
ommended to perform more studies to obtain more 
definite results. 
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